102 related articles for article (PubMed ID: 21131761)
1. Serum fucose level in malignant diseases.
Sawke NG; Sawke GK
Indian J Cancer; 2010; 47(4):452-7. PubMed ID: 21131761
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors.
Tatsumura T; Sato H; Mori A; Komori Y; Yamamoto K; Fukatani G; Kuno S
Cancer Res; 1977 Nov; 37(11):4101-3. PubMed ID: 908042
[TBL] [Abstract][Full Text] [Related]
3. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
Ghosh M; Nayak BR
Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of serum protein bound fucose as a diagnostic and prognostic index in malignant tumours.
Dutta TK; Sengupta U; Gupta BD
Indian J Cancer; 1976 Sep; 13(3):262-6. PubMed ID: 1010590
[No Abstract] [Full Text] [Related]
5. Clinical value of protein-bound fucose in patients with carcinoma and other diseases.
Lambana S
Gan; 1976 Jun; 67(3):379-88. PubMed ID: 1001865
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
Patel PS; Baxi BR; Adhvaryu SG; Balar DB
Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
[TBL] [Abstract][Full Text] [Related]
7. [Standards, options and recommendations for tumor markers in colorectal cancer].
Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic significance of serum fucose in various malignant diseases.
Pradhan SL; Dixit CV; Shah AK
Indian J Pathol Microbiol; 1979 Jan; 22(1):21-6. PubMed ID: 544480
[No Abstract] [Full Text] [Related]
9. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.
Gilligan TD; Seidenfeld J; Basch EM; Einhorn LH; Fancher T; Smith DC; Stephenson AJ; Vaughn DJ; Cosby R; Hayes DF;
J Clin Oncol; 2010 Jul; 28(20):3388-404. PubMed ID: 20530278
[TBL] [Abstract][Full Text] [Related]
10. Serum tumour markers in clinical practice. Some general aspects.
Kvinnsland S
Scand J Clin Lab Invest Suppl; 1991; 206():6-11. PubMed ID: 1947761
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias.
Patel PS; Adhvaryu SG; Balar DB; Parikh BJ; Shah PM
Anticancer Res; 1994; 14(2B):747-51. PubMed ID: 8010734
[TBL] [Abstract][Full Text] [Related]
12. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
Shashikanth MC; Rao BB
Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
[TBL] [Abstract][Full Text] [Related]
13. [Application of tumour markers in clinical practice].
Keuren JF; Thomas CM; Bonfrèr JM; Sweep CG; Boonstra JG
Ned Tijdschr Geneeskd; 2009; 153():A617. PubMed ID: 19857306
[TBL] [Abstract][Full Text] [Related]
14. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of total and lipid-bound sialic acid in malignancies].
Cylwik B; Chrostek L; Szmitkowski M
Pol Merkur Lekarski; 2005 Aug; 19(110):237-41. PubMed ID: 16245443
[TBL] [Abstract][Full Text] [Related]
16. [Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group].
Basuyau JP; Blanc-Vincent MP; Bidart JM; Daver A; Deneux L; Eche N; Gory-Delabaere G; Pichon MF; Riedinger JM
Bull Cancer; 2000 Oct; 87(10):723-37. PubMed ID: 11084536
[TBL] [Abstract][Full Text] [Related]
17. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
Ebert W; Muley T; Drings P
Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive molecular markers in colorectal carcinoma.
Bendardaf R; Lamlum H; Pyrhönen S
Anticancer Res; 2004; 24(4):2519-30. PubMed ID: 15330208
[TBL] [Abstract][Full Text] [Related]
19. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
[TBL] [Abstract][Full Text] [Related]
20. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.
Bolander A; Agnarsdóttir M; Wagenius G; Strömberg S; Pontén F; Ekman S; Brattström D; Larsson A; Einarsson R; Ullenhag G; Hesselius P; Bergqvist M
Melanoma Res; 2008 Dec; 18(6):412-9. PubMed ID: 19011512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
